ϩ B cells and the low incidence or absence of somatic mutation in normal CD5 ϩ B cells, we speculate that CD5 ϩ B cells usually do not participate in germinal center reactions, but if they occasionally do so, they may be at an increased risk to become involved in autoimmune diseases or B cell malignancies. (
Introduction
B lymphocytes expressing the CD5 antigen are the predominant B cell population early in life (1, 2) . Later, their number is reduced, and CD5 ϩ B cells account for ‫ف‬ 10-25% of peripheral blood (PB) 1 B cells in man (1) (2) (3) . These cells are also found in spleen and tonsil at a comparable frequency (1) (2) (3) . One characteristic feature of CD5 ϩ B cells (also called B1a cells) is that many of them produce autoreactive antibodies, which are usually polyreactive (4) . Numbers of CD5 ϩ B cells are elevated in certain autoimmune diseases, and in some of these cases CD5 ϩ B cells producing high-affinity autoantibodies have been detected (4) (5) (6) (7) . A relationship between CD5 ϩ B cells and autoimmunity is further suggested by the finding that mouse strains harboring elevated levels of CD5 ϩ B cells are prone to autoimmune diseases (1) . CD5
ϩ B cells are also involved in certain B cell malignancies. More than 95% of cases of B cell chronic lymphocytic leukemia (B-CLL), the most common leukemia of adults in the Western world, express CD5 (1) . In addition, CD5 is regularly found on tumor B cells in small lymphocytic lymphoma (1) .
The origin of CD5 ϩ B cells in humans and mice is much debated (1, 8) . Since CD5 expression can be induced in vitro on CD5-negative B cells, it has been suggested that CD5 represents an activation marker (9) . In the induction/selection model, B cells recognizing autoantigens with low affinity are selected to become CD5 ϩ B cells (10) . On the other hand, transfer experiments in mice support a dual-lineage model that states that CD5-positive and CD5-negative (conventional) B cells represent distinct lineages of B cells (11) . Those transfer experiments also revealed that CD5 ϩ B cells repesent a selfreplenishing population of long-lived lymphocytes (12, 13) .
Immunoglobulin V genes expressed by CD5 ϩ B cells have been the subject of a large number of studies. A sequence analysis of immunoglobulin V region genes allows one to gain insight into the stage of differentiation of the respective B cell. Immature and naive B cells carry unmutated variable (V) region genes (14) (15) (16) (17) . Somatic mutations are introduced into rearranged V genes in the course of T cell-dependent immune reactions (14, 18) . This process takes place in the microenvironment of the germinal center (GC) (19) (20) (21) . Consequently, somatically mutated V region genes are found in GC B cells and their descendants, i.e., memory B cells and GC-derived plasma cells (16, 17, 21) . Whereas murine CD5
ϩ B cells express unmutated V region genes (22) (23) (24) , the situation appears to be different in the human: somatically mutated V genes have been described in cases of CD5-expressing B-CLL (25) (26) (27) (28) and in CD5 ϩ B cells producing high-affinity autoantibodies (5, 6) . Moreover, somatic mutations have been reported to be present in V genes of CD5 ϩ B cells isolated from healthy donors (16, 29, 30) . These findings suggest that in terms of somatic mutation, there is no difference between CD5 ϩ B cells and conventional B cells in humans.
Two findings prompted us to reinvestigate the issue of the occurrence and frequency of CD5 ϩ B cells carrying somatically mutated V genes in healthy individuals: first, most CD5 ϩ B cells are found among IgM ϩ IgD ϩ B lymphocytes (2, 3) . The vast majority of these naive B cells, however, carry unmutated V region genes (15) (16) (17) 31) , which also implies that most CD5 ϩ B cells express unmutated V genes. Obviously, this result contrasts with the V gene studies on CD5 ϩ B cells in healthy individuals (16, 29, 30 
IgD
ϩ B cells (31) . Since the studies on CD5 ϩ B cells of healthy donors were carried out by amplifying V region gene transcripts from cell populations (16, 29, 30) , those investigations might be biased towards somatically mutated V genes.
To overcome these problems, we sorted single CD5 ϩ B cells by flow cytometry, and amplified rearranged V genes from genomic DNA of individual cells. PCR products were sequenced directly. This approach should allow one to determine reliably the frequency of CD5 ϩ B cells carrying mutated V region genes.
Methods
Isolation of single cells and flow cytometry. 60-100 ml PB was obtained from three male, healthy donors ages 27-35. PB mononuclear cells (MC) were purified by Ficoll-Isopaque density centrifugation, and were incubated with unconjugated antihuman light chain (IgG1-isotype, Becton Dickinson, Mountain View, CA) for 15 min on ice. After washing, the cells were incubated with goat anti-mouseIgG1 microbeads (Miltenyi Biotec Inc., Bergisch Gladbach, Germany) for 20 min at 4 Њ C. Subsequently, -expressing B cells were enriched to Ͼ 90% by magnetic cell separation using the MiniMACS™ system (Miltenyi Biotec Inc.) (15) . For isolation of single CD5 ϩ CD19 ϩ B cells from donor HK, the cell suspension was incubated with anti-CD5-PE and anti-CD19-FITC (Becton Dickinson). The cell suspensions from the other two donors were stained with anti-CD5-FITC (Becton Dickinson), goat anti-human (GaH)-IgM-PE (Sigma Chemical Co., München, Germany), and biotinylated GaH-IgD (Southern Biotechnology Associates, Birmingham, AL). After washing, GaHIgD was developed with Streptavidin-CyChrome (PharMingen, San Diego, CA). All staining procedures were performed for 15 min on ice. ) were sorted into reaction tubes as described above.
The size of CD5 Single cell PCR and sequencing of PCR products. Single cells were incubated in 20 l PCR buffer containing 0.5 mg/ml proteinase K for 1 h at 50 Њ C. The enzyme was inactivated by denaturation at 95 Њ C (10 min). For the first round of amplification, a primer mix consisting of four V family-specific primers, which recognize sequences in the framework region I of the members of the V 1-4 gene families, and a downstream primer specific for a sequence 3 Ј of J 5 was used (see Table I ). This approach prevents amplification of V -J 1,2,3 & 4 rearrangements that have been located away from the C locus by inversion (32) , and therefore presumably do not undergo somatic hypermutation due to their large distance from both the intron and the 3 Ј -enhancer (33) . Owing to the small distance between the five J gene segments, however, V J rearrangements lying in the proper location in the Ig locus can be efficiently amplified with a primer 3 Ј of the last J gene. The first round of amplification was carried out in the same reaction tube in a 50-l volume containing Expand™ High Fidelity buffer (Boehringer Mannheim, Mannheim, Germany), 1.75 mM MgCl 2 , 100 M dATP, dGTP, dTTP, and dCTP, respectively, 50 nM of each primer, and 2.5 U Expand™ High Fidelity polymerase (Boehringer Mannheim). The amplification program consisted of 35 cycles of 60 s at 95 Њ C, 30 s at 61 Њ C, and 80 s at 72 Њ C, followed by a final incubation step at 72 Њ C for 5 min. Enzyme was added after the first denaturation step. For the second round of amplification, the same V family-specific primers were used together with three internal Jspecific primers hybridizing to the five human J gene segments (see Table I ). The second round of amplification was performed in separate reactions for each of the four V primers using 1 l of the firstround reaction mixture in a 50-l volume containing 10 mM TrisHCl, pH 8.3 (20 Њ C), 50 mM KCl, 2.0 mM MgCl 2 , 100 M dATP, dGTP, dTTP, and dCTP, respectively, 125 nM of each primer, and 0.7 U Taq DNA polymerase (Boehringer Mannheim). The amplification conditions were as described above, except that the elongation step at 72 Њ C was carried out for 60 s, and 40 cycles were applied. PCR products were purified by gel electrophoresis. An aliquot of the isolated DNA was sequenced directly with 32 P-labeled oligonucleotides of the second round using the dsDNA Cycle Sequencing System (GIBCO BRL, Eggenstein, Germany) as recommended by the supplier. Nucleotide sequences were analyzed using DNASIS™ software (Pharmacia, Freiburg, Germany). In some cases, it was not possible to determine by sequence analysis which of the five J gene segments had been rearranged. In these cases, the second round of PCR was repeated using the respective V family-specific primer together with each of the J -specific primers in separate reactions (J typing).
Statistical analysis. Differences in the proportions of cells carrying mutated V genes, and differences in the proportions of potentially functional V genes with complementarity-determining region 
CD5
ϩ B cells were assessed statistically using Fisher's exact test.
Results

V gene sequences of CD19
ϩ CD5 ϩ B cells. After enrichment of light chain-expressing PB B cells from donor HK by magnetic cell separation, single cells of the CD19 ϩ
CD5
ϩ fraction, which amounted to ‫ف‬ 20% of the B cell compartment, were isolated by fluorescence-activated cell sorting (Fig. 1 ). Rearranged V genes of individual cells were amplified from genomic DNA using a seminested PCR strategy (31) . The experiment was restricted to analysis of V region genes since the human immunoglobulin locus is well characterized, and human V germline genes seem to exhibit only little polymorphism, which allows unambiguous identification of somatic mutations in rearranged V genes (34, 35) . Negative controls consisted of one single T cell, plus one reaction mixture without cells per seven B lymphocytes analyzed. None of these negative controls gave rise to a PCR product.
Of 14 CD5 ϩ B cells analyzed by PCR, 11 cells gave rise to a total of 14 amplificates, 12 of which were sequenced (Fig. 2 ). All sequences represented unique V J joints. Cell X8 carried one in-frame and one out-of-frame rearrangement, whereas cell X9 showed only a single out-of-frame rearrangement. Cell X12 gave rise to two potentially functional V region genes. This result may be explained by the fact that two cells had been sorted into the reaction tube at the isolation step. Another possibility is that one of the light chains, though the gene segments had been functionally assembled, was unable to pair properly with the H chain expressed by the cell, and therefore an additional rearrangement occurred in the second Ig locus (36, 37) . From each of the remaining seven cells, a single in-frame rearrangement was obtained. Whereas V gene rearrangements X5K4 and X8K1 showed two basepairs difference each compared to the most homologous V germline genes, the other ten V sequences turned out to be unmutated ( Fig. 2 and Table II ). This result indicates that the majority of human CD5 ϩ PB B cells carry unmutated V region genes. It does not, however, exclude the possibility that a small subset of mutated CD5 ϩ B cells might exist in human PB.
Table I. Sequences of Oligonucleotides Used as Primers for the Amplification of Rearranged V Genes
Oligonucleotide Sequence
The V primers hybridize to the framework region I of the respective family. ϽϾ denotes a nucleotide mix at this position. § range of mutations per gene. ʈ Mutation frequencies were calculated by considering the nucleotide differences in the V region genes relative to the corresponding V and J germline genes, except for the non-germline-encoded nucleotides at the V J junctions. Sequences are designated by an X and a sample number of the cell, followed by the corresponding V family to which the sequence was assigned. Shown are the 3Ј end of the respective V gene, N-region nucleotides (N), and the 5Ј end of J . In addition, the corresponding V and J germline genes are indicated. J genes identified by J typing (see Methods) are denoted by *. The sum of nucleotide differences relative to the corresponding germline genes is shown in the right column. Codons are numbered according to Kabat et al. (74) . Full-length sequences are available from EMBL/GenBank under accession nos. Z98605-Z98679. analysis revealed in all cases that CD5-expressing cells were barely detectable (i.e., Ͻ 1%) among isotype-switched B cells (Fig. 3) . On the other hand, we reported in a previous study on a small fraction of CD5 ϩ B lymphocytes within the PB IgMonly compartment (31) . This result was confirmed by flow-cytometric analysis of PB B cells (from donors RK and AB) that were enriched by magnetic cell separation and stained with anti-IgM, anti-IgD, and anti-CD5 (Fig. 4) . The fraction of 
V gene sequences of IgM
IgD
Ϫ subset. From donor RK, single cells of all three fractions were isolated twice in two separate experiments. Single-cell PCR and sequencing were performed as described above. Taking both donors together, a total of 106 cells were analyzed by PCR. 52 cells gave rise to a single, and 10 cells to two distinct PCR products. 63 amplificates from 55 cells were sequenced, all of which represented unique V J rearrangements (Fig. 5) . Eleven cells showed a single out-of-frame rearrangement, whereas six cells carried both a productive and a nonproductive V J joint. Again, two cells (C6 and F23) gave rise to two distinct in-frame rearrangements each. The remaining 36 cells revealed a single potentially functional V region gene each.
15 out of 18 rearrangements of the CD5 Ϫ IgM-only compartment turned out to be mutated (range: 2-16 mutations, Figs. 5 and 6 and Table II) . Interestingly, the three unmutated sequences represented out-of-frame V J joints (Fig. 5 ). These three genes may be derived from cells that carry somatic mutations in the heavy chain and functional light chain genes: in some light chain-expressing B cells, the second (presumably nonfunctional) rearranged allele is inactivated by deletion of the C gene and the enhancers, leaving the V J joint untouched (41) . This deletion most likely abolishes somatic mutation in the respective V J joint (33, 42) . The frequency of somatic mutation of CD5 Ϫ IgM-only PB B lymphocytes was calculated to be 2.5% for donor RK, and 2.0% for donor AB (Table II) . Both values are in a similar range to mutation frequencies observed for IgM-only PB B cells in previous studies (15, 31) . In contrast, only 3 out of 21 rearrangements of the CD5 ϩ IgM-only subset harbored somatic mutations (1, 4, and 4 nucleotide exchanges), whereas the other 18 sequences were identical to the corresponding V and J germline genes (Figs. 5 and 6 and Table II ). In addition, among 24 rearrangements obtained from CD5 Table II) .
Evidence for a novel polymorphic J 2 gene segment. The J 2 gene segment was found to be rearranged in eleven clonally independent V region genes obtained from cells of donor RK (Fig. 5 A) . Position two of codon 97 of the respective rearranged J 2 genes differed from the published J 2 germline gene (43) by a C to G nucleotide exchange in nine of these rearrangements. Since six of those V region genes carried no mutation in the rest of their sequence, it is unlikely that the C to G exchanges represent somatic mutations. The result rather suggests that donor RK is heterozygous for a previously unidentified polymorphic J 2 gene which replaces a threonine (encoded by ACT) by a serine (AGT) at the last position of the CDRIII. A search in the European Molecular Biology Laboratories database (release 95) revealed that a J 2 gene with AGT at codon 97 was previously sequenced from three other individuals, although this was not identified as a polymorphism in those studies (44) (45) (46) . Thus, we identified a novel, albeit rare J 2 gene polymorphism.
V gene usage of CD5 ϩ B cells. We obtained 43 potentially functional V J joints from CD5 ϩ B cells. The sequences could be assigned to a total of 16 different V germline genes of the V gene families 1, 2, 3, and 4. Nine sequences showed highest homology to the V 3 gene A27, five sequences each to the single V 4 (B3) gene and the A3/A19 (V 2) gene, and four sequences to O2/O12 (V 1). Three sequences each could be assigned to L12A (V 1), L2 (V 3), and L6 (V 3). Nine V germline genes were found to be rearranged either once or twice (Figs. 2 and 5 ). The V genes that have been used frequently by CD5 ϩ B cells in this study, in particular A27, were also found to be overrepresented in compilations of rearranged V sequences, the majority of which were derived from conventional B cells (35, 47) . Thus, it appears that human CD5 ϩ PB B cells do not differ considerably from conventional B cells with regard to V gene usage.
N-region additions at V J junctions of CD5
ϩ B cells. A hallmark of murine B cells developing early in ontogeny, a substantial fraction of which belongs to the CD5-expressing subset (1, 48) , is the rare occurrence of non-germline-encoded nucleotides at the V H D H J H junctions (49, 50) . On the other hand, N-region additions have frequently been detected in CD5 ϩ B cells obtained from adult mice, even though less frequently than in conventional B cells (62% versus 93%) (49) (50) (51) .
In contrast, N sequences are a common feature of human B lymphocytes already in the fetus, and they appear to be consistently present at V H D H J H junctions of B cells in the adult (52, 53) . Moreover, IgH CDRIII sequences derived from CD5 ϩ and CD5
Ϫ human cord blood B cells revealed no significant difference with respect to the frequency of N-region additions (54) . In our collection of 57 V gene rearrangements amplified from CD5 ϩ B cells of three adult donors, 34 contained nongermline-encoded nucleotides at their V J junctions (60%), whereas N sequences were found at 10 out of 18 V J junctions derived from CD5 Ϫ B cells (56%) (Figs. 2 and 5 ). These data, therefore, support the notion that N-region additions occur frequently in human CD5 ϩ B cells, and that the frequency, unlike in the mouse, does not differ from that of conventional B cells.
CDRIII lengths of potentially functional V region genes. (Fig. 5) . The difference between the CD5 Ϫ subset on the one hand, and the CD5 
IgD
ϩ subset on the other, was statistically significant (P ϭ 0.005 and P ϭ 0.012, respectively). In contrast, the two CD5 ϩ B cell fractions did not differ significantly from each other (P ϭ 0.461).
Since it has been suggested that CD5-expressing B cells are involved in autoimmune diseases, particularly in rheumatoid arthritis (1, (5) (6) (7) , it is interesting to note that Bridges et al. recently reported on increased proportions of V transcripts with unusually long CDRIIIs amplified from synovia and PB of patients with rheumatoid arthritis as compared to healthy individuals (55) . This overrepresentation, however, was rather due to an increase in V J joints containing CDRIIIs of 11 amino acids, than to an increase in those with CDRIIIs of 10 amino acids, the latter being overrepresented in the CD5 ϩ subsets of this study. Thus, the relationship between CD5-positive B cells carrying V region genes with extended CDRIII lengths and B cells expressing V region genes with long CDRIIIs in patients suffering from rheumatoid arthritis remains to be clarified.
Analysis of tonsillar B cell subsets with regard to CD5 expression. To determine whether the distribution of CD5 on B cell subsets derived from secondary lymphoid organs resembles that seen in the PB, we analyzed tonsillar B cells for expression of CD5 on IgM-expressing, as well as on isotypeswitched B lymphocytes. Besides naive and memory B cells, the tonsil contains a large fraction of GC B cells (17) . These cells are known to be CD5-negative (56) . To avoid masking in the flow cytometric analysis of tonsillar memory and naive B cells for CD5 expression by the numerous GC B cells, we depleted the latter, and, in addition, T cells, by magnetic cell separation. Concerning the pattern of IgM and IgD expression on the enriched cells, we were surprised to find only two of seven tonsils showing a clearly discernible IgM-only subpopulation. Whereas most tonsils were derived from children or young adults (ages 5-19), these two tonsils were from donors over 30 years old, suggesting that IgM-expressing memory cells in this tissue accumulate with age. In one of these cases, expression of CD5 on IgM Fig. 7 shows that, whereas a sizeable proportion of IgD-positive B cells expressed CD5, few if any CD5-positive cells could be detected among IgG ϩ and IgA ϩ B cells. Thus, at least in the case of the tonsil, the expression pattern of CD5 on B cell subsets of secondary lymphoid organs mirrors that seen on the corresponding PB B lymphocyte subsets (Figs. 3, 4, and 7) .
Discussion
Previous investigations suggested that CD5
ϩ B cells in healthy individuals regularly acquire somatic mutations. In three RNA-based studies, somatic mutations were found in 12/ 16 (29) , 16/23 (30) , and 5/8 (16) V gene transcripts amplified from populations of CD5 ϩ B cells isolated by flow cytometry. In yet another RNA-based study, the ratio of mutated to unmutated V genes (3/9) was lower (46) . Moreover, 16 cell lines generated by EBV transformation of CD5 ϩ B cells from healthy adult donors have been described in the literature (25, (57) (58) (59) . Among those lines, 12 have been reported to be mutated. Collectively, these studies suggested that the majority of CD5 ϩ B cells in healthy humans express somatically mutated V genes.
Despite the conformity of these data, the following observations prompted us to reinvestigate V genes of human CD5 not represent a suitable approach to determine the frequency of CD5 ϩ B cells harboring mutated V genes. Furthermore, the collection of EBV lines derived from CD5 ϩ B cells is clearly not representative of the CD5 ϩ B cell population; two of the lines harboring mutated V genes express isotypes other than IgM (57), which is atypical for CD5 ϩ B cells, as we and others have shown (Figs. 3 and 7) (40, 60) . In addition, in the work of Schutte et al. (59) , the two lines analyzed were the only ones that expressed CD5 among 500 lines established from adult PB. This underrepresentation of CD5-expressing EBV lines is not surprising, since sorted CD5 ϩ B cells usually lose CD5 expression upon EBV immortalization (59, 61) . Under these circumstances, the two CD5-positive lines can hardly be regarded as being representative of CD5 ϩ B cells. Nevertheless, analyses of the EBV lines indicate that some CD5
ϩ B cells carrying somatic mutations can be found in healthy adults, although their frequency cannot be reliably determined from those investigations (25, (57) (58) (59) .
The vast majority of CD5 ϩ PB B cells in healthy humans carry unmutated V region genes. In this study, CD5-expressing PB B cells derived from healthy adults were analyzed for the level of somatic mutation in rearranged V genes by single-cell PCR. This approach has several advantages when compared with the analysis of cell lines or cDNA-libraries generated from cell populations (62); a single-cell experiment is obviously not biased by varying transcript levels or by preferential EBV transformation of particular subsets of cells. By analyzing single cells, the frequency of B cells harboring somatically mutated V region genes within a B cell subset can be reliably determined. Furthermore, single-cell PCR allows unambiguous identification of somatic mutations in contrast to cell population analyses that involve cloning of PCR products. Amplificates obtained from single cells can be sequenced directly without being cloned, and therefore sequence errors due to misincorporation by Taq DNA polymerase are negligible.
In a first experiment, V region genes of single CD5 ϩ CD19 ϩ PB B cells were investigated. Among 10 cells analyzed, 2 V J joints showed 2 mutations each, whereas the remaining rearranged V genes were identical to their corresponding germline genes ( Fig. 2 and Table II ). This result indicates that the majority of CD5 ϩ B cells in healthy humans carry unmutated V genes.
Since the finding of two slightly mutated V genes in the analysis of CD5 ϩ
CD19
ϩ PB B cells might imply that a subset of CD5 ϩ B cells carries mutated V genes, we sought a way to identify such a putative subpopulation. In man, CD5 ϩ B cells are found among IgM-expressing, but not among isotypeswitched PB B lymphocytes (Figs. 3 and 4) (15, 17) , and of about 5-10% IgM-only B cells, the majority of which were shown to carry mutated V gene rearrangements (31) . Both of these subsets contain a fraction of CD5-expressing B lymphocytes ‫ف(‬ 20 and 10%, respectively) (Fig. 4) . Thus, if CD5 ϩ B cells harboring mutated V genes exist, one might expect to find them within the IgM-only population.
Single IgM-only and single IgM (63) (64) (65) (66) (67) , it has become clear that a considerable fraction of cases of CD5-positive B-CLL and prolymphocytic leukemia harbor somatically mutated V region genes (25) (26) (27) (28) (68) (69) (70) . In addition, mutated V genes were also found in each of six EBV-immortalized, flow-cytometrically isolated CD5 ϩ B cells producing high-affinity, monoreactive autoantibodies derived from patients suffering from autoimmune diseases (5, 6 ϩ B cell population of healthy individuals is characterized by unmutated V region genes. How can this apparent discrepancy be explained?
One possibility would be that the disease-involved CD5-expressing B cells are not derived from CD5 ϩ B cells, but rep-resent conventional B cells that began to express CD5 on the cell surface after they left the GC. This hypothesis finds support in the observation that CD5 expression can be induced on conventional B cells in vitro (9) . One can also, however, envision an alternative scenario (see reference 8). CD5
ϩ B cells represent a population of cells, many of which produce low-affinity, poly-and autoreactive antibodies (4). These cells usually do not participate in T celldependent immune reactions, and hence do not establish GCs. In rare cases, however, CD5 ϩ B cells may be drawn into a GC reaction, and within this microenvironment, undergo somatic hypermutation. Through this process, low-affinity autoantibodies may give rise to high-affinity, pathogenic autoantibodies, as they have been detected in patients suffering from autoimmune diseases (5, 6) . The vigorous clonal expansion of GC B cells and the processes of somatic hypermutation and class switch recombination may put the long-lived CD5 ϩ B cells (71) at an increased risk for malignant transformation, because these activities may raise the chance to acquire transforming events. As a consequence, cases with mutated V genes would be overrepresented among B-CLLs.
The assumption that CD5 ϩ B cells normally do not participate in GC reactions is supported by transfer experiments in the mouse that showed that CD5 ϩ B cells only poorly reconstitute GCs (8, 72) . In addition, these results argue against the possibility that CD5 ϩ B cells may establish GCs, and upon doing so, lose CD5 expression, thereby generating CD5 Ϫ GC descendants. The scenario discussed in the previous paragraph finds further support by many similarities between the tumor cells in CD5 ϩ B-CLL and CD5 ϩ B cells, indicating their derivation from CD5 ϩ and not from conventional B cells (73). Collectively, the aspects mentioned here support the view that CD5 ϩ B cells, only in rare instances proliferate and mutate within a GC, but if they do so, they are at an increased risk to become involved in immune dysfunctions.
